| Hydrogen sulfide dysregulates the immune response by suppressing central carbon metabolism to promote tuberculosis MA Rahman, BM Cumming, KW Addicott, HT Pacl, SL Russell, K Nargan, ... Proceedings of the National Academy of Sciences 117 (12), 6663-6674, 2020 | 74 | 2020 |
| Relevance of the Warburg effect in tuberculosis for host-directed therapy BM Cumming, HT Pacl, AJC Steyn Frontiers in cellular and infection microbiology 10, 576596, 2020 | 36 | 2020 |
| Host-pathogen redox dynamics modulate Mycobacterium tuberculosis pathogenesis HT Pacl, VP Reddy, V Saini, KC Chinta, AJC Steyn Pathogens and Disease 76 (5), fty036, 2018 | 34 | 2018 |
| A high‐resolution 3D atlas of the spectrum of tuberculous and COVID‐19 lung lesions G Wells, JN Glasgow, K Nargan, K Lumamba, R Madansein, K Maharaj, ... EMBO molecular medicine 14 (11), e16283, 2022 | 14 | 2022 |
| Water-soluble tocopherol derivatives inhibit SARS-CoV-2 RNA-dependent RNA polymerase HT Pacl, JL Tipper, RR Sevalkar, A Crouse, C Crowder, ... bioRxiv, 2021.07. 13.449251, 2021 | 12 | 2021 |
| NAD (H) homeostasis underlies host protection mediated by glycolytic myeloid cells in tuberculosis HT Pacl, KC Chinta, VP Reddy, S Nadeem, RR Sevalkar, K Nargan, ... Nature Communications 14 (1), 5472, 2023 | 9 | 2023 |
| Heme oxygenase-1 as a pharmacological target for host-directed therapy to limit tuberculosis associated immunopathology KC Chinta, HT Pacl, A Agarwal, AJC Steyn Antioxidants 10 (2), 177, 2021 | 9 | 2021 |
| Comparison of integrated behavioral health treatment for internalizing psychiatric disorders in patients with and without Type 2 diabetes. AR Andrews III, D Gomez, A Larey, H Pacl, D Burchette Jr, ... Families, Systems, & Health 34 (4), 367, 2016 | 8 | 2016 |
| The Institute of NNCAJ Paul | 3 | 2021 |
| NAD (H) homeostasis is essential for host protection mediated by glycolytic myeloid cells in tuberculosis HT Pacl, KC Chinta, VP Reddy, S Nadeem, RR Sevalkar, K Nargan, ... bioRxiv, 2022.09. 11.507472, 2022 | 2 | 2022 |
| Identification and Assessment of FDA-Approved Drugs for Repurposing as Single and Combination Therapies Against SARS-CoV-2 Infection HT Pacl, JL Tipper, GD Holder, RR Sevalkar, S Nadeem, KC Chinta, ... TP91. TP091 EPIDEMIOLOGY AND TRANSLATIONAL ADVANCES IN SARS-COV-2, A3767-A3767, 2021 | | 2021 |
| Glycolytic Myeloid Cells Protect the Host in Tuberculosis HT Pacl The University of Alabama at Birmingham, 2021 | | 2021 |
